Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Condition(s):IGF1 DeficiencyLast Updated:March 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):IGF1 DeficiencyLast Updated:March 28, 2024Recruiting
Condition(s):Insulin-Like Growth Factor-1 Deficiency; Growth DisordersLast Updated:July 27, 2020Completed
Condition(s):Androgen Receptor Abnormal; Insulin-Like Growth Factor I Deficiency; Insulin Receptor, Defect inLast Updated:January 14, 2021Unknown status
Condition(s):IGF1 DeficiencyLast Updated:September 7, 2017Unknown status
Condition(s):IGF-1 DeficiencyLast Updated:January 11, 2019Terminated
Condition(s):Insulin-like Growth Factor-1 DeficiencyLast Updated:March 30, 2023Terminated
Condition(s):Growth DisordersLast Updated:August 14, 2020Terminated
Condition(s):Growth Disorders; Insulin-Like Growth Factor-1 DeficiencyLast Updated:September 18, 2019Completed
Condition(s):Insulin Growth Factor I Deficiency; IGF1 Deficiency; Executive Function DisorderLast Updated:December 8, 2022Recruiting
Condition(s):Growth Hormone DeficiencyLast Updated:June 6, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.